The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Colorectal Cancer Molecular Diagnostics Kit Market Research Report 2025
Synopsis
The main techniques involved in molecular testing for CRC are PCR based methods, DNA sequencing and immunohistochemistry analysis of tissue sections. These methods are currently used for diagnosis of Lynch syndrome by detection of MSI phenotype and discriminating them from sporadic CRC by looking for BRAF mutation.
Global Colorectal Cancer Molecular Diagnostics Kit market is projected to reach US$ 1725.7 million in 2029, increasing from US$ 684 million in 2022, with the CAGR of 14.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Colorectal Cancer Molecular Diagnostics Kit market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Colorectal Cancer Molecular Diagnostics Kit market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche
Abbott
Thermo Fisher
Kej
Illumina
Bio Mérieux
Bio-Rad Life Medicine
Agilent
Daan Gene
Ed Bio
Segment by Type
PCR
Molecular Hybridization
Biochip
Other
Segment by Application
Hospital
Third-party Testing Agency
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Colorectal Cancer Molecular Diagnostics Kit report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
The main techniques involved in molecular testing for CRC are PCR based methods, DNA sequencing and immunohistochemistry analysis of tissue sections. These methods are currently used for diagnosis of Lynch syndrome by detection of MSI phenotype and discriminating them from sporadic CRC by looking for BRAF mutation.
Global Colorectal Cancer Molecular Diagnostics Kit market is projected to reach US$ 1725.7 million in 2029, increasing from US$ 684 million in 2022, with the CAGR of 14.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Colorectal Cancer Molecular Diagnostics Kit market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Colorectal Cancer Molecular Diagnostics Kit market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche
Abbott
Thermo Fisher
Kej
Illumina
Bio Mérieux
Bio-Rad Life Medicine
Agilent
Daan Gene
Ed Bio
Segment by Type
PCR
Molecular Hybridization
Biochip
Other
Segment by Application
Hospital
Third-party Testing Agency
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Colorectal Cancer Molecular Diagnostics Kit report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Molecular Diagnostics Kit Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 PCR
1.2.3 Molecular Hybridization
1.2.4 Biochip
1.2.5 Other
1.3 Market by Application
1.3.1 Global Colorectal Cancer Molecular Diagnostics Kit Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Third-party Testing Agency
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Molecular Diagnostics Kit Market Perspective (2018-2029)
2.2 Colorectal Cancer Molecular Diagnostics Kit Growth Trends by Region
2.2.1 Global Colorectal Cancer Molecular Diagnostics Kit Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Colorectal Cancer Molecular Diagnostics Kit Historic Market Size by Region (2018-2023)
2.2.3 Colorectal Cancer Molecular Diagnostics Kit Forecasted Market Size by Region (2024-2029)
2.3 Colorectal Cancer Molecular Diagnostics Kit Market Dynamics
2.3.1 Colorectal Cancer Molecular Diagnostics Kit Industry Trends
2.3.2 Colorectal Cancer Molecular Diagnostics Kit Market Drivers
2.3.3 Colorectal Cancer Molecular Diagnostics Kit Market Challenges
2.3.4 Colorectal Cancer Molecular Diagnostics Kit Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Molecular Diagnostics Kit Players by Revenue
3.1.1 Global Top Colorectal Cancer Molecular Diagnostics Kit Players by Revenue (2018-2023)
3.1.2 Global Colorectal Cancer Molecular Diagnostics Kit Revenue Market Share by Players (2018-2023)
3.2 Global Colorectal Cancer Molecular Diagnostics Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Molecular Diagnostics Kit Revenue
3.4 Global Colorectal Cancer Molecular Diagnostics Kit Market Concentration Ratio
3.4.1 Global Colorectal Cancer Molecular Diagnostics Kit Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Molecular Diagnostics Kit Revenue in 2022
3.5 Colorectal Cancer Molecular Diagnostics Kit Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Molecular Diagnostics Kit Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Molecular Diagnostics Kit Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Molecular Diagnostics Kit Breakdown Data by Type
4.1 Global Colorectal Cancer Molecular Diagnostics Kit Historic Market Size by Type (2018-2023)
4.2 Global Colorectal Cancer Molecular Diagnostics Kit Forecasted Market Size by Type (2024-2029)
5 Colorectal Cancer Molecular Diagnostics Kit Breakdown Data by Application
5.1 Global Colorectal Cancer Molecular Diagnostics Kit Historic Market Size by Application (2018-2023)
5.2 Global Colorectal Cancer Molecular Diagnostics Kit Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Colorectal Cancer Molecular Diagnostics Kit Market Size (2018-2029)
6.2 North America Colorectal Cancer Molecular Diagnostics Kit Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2018-2023)
6.4 North America Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Colorectal Cancer Molecular Diagnostics Kit Market Size (2018-2029)
7.2 Europe Colorectal Cancer Molecular Diagnostics Kit Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2018-2023)
7.4 Europe Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Market Size (2018-2029)
8.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Market Size by Region (2018-2023)
8.4 Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Molecular Diagnostics Kit Market Size (2018-2029)
9.2 Latin America Colorectal Cancer Molecular Diagnostics Kit Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2018-2023)
9.4 Latin America Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Market Size (2018-2029)
10.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2018-2023)
10.4 Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Colorectal Cancer Molecular Diagnostics Kit Introduction
11.1.4 Roche Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Colorectal Cancer Molecular Diagnostics Kit Introduction
11.2.4 Abbott Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2018-2023)
11.2.5 Abbott Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Detail
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Kit Introduction
11.3.4 Thermo Fisher Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2018-2023)
11.3.5 Thermo Fisher Recent Development
11.4 Kej
11.4.1 Kej Company Detail
11.4.2 Kej Business Overview
11.4.3 Kej Colorectal Cancer Molecular Diagnostics Kit Introduction
11.4.4 Kej Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2018-2023)
11.4.5 Kej Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina Colorectal Cancer Molecular Diagnostics Kit Introduction
11.5.4 Illumina Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2018-2023)
11.5.5 Illumina Recent Development
11.6 Bio Mérieux
11.6.1 Bio Mérieux Company Detail
11.6.2 Bio Mérieux Business Overview
11.6.3 Bio Mérieux Colorectal Cancer Molecular Diagnostics Kit Introduction
11.6.4 Bio Mérieux Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2018-2023)
11.6.5 Bio Mérieux Recent Development
11.7 Bio-Rad Life Medicine
11.7.1 Bio-Rad Life Medicine Company Detail
11.7.2 Bio-Rad Life Medicine Business Overview
11.7.3 Bio-Rad Life Medicine Colorectal Cancer Molecular Diagnostics Kit Introduction
11.7.4 Bio-Rad Life Medicine Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2018-2023)
11.7.5 Bio-Rad Life Medicine Recent Development
11.8 Agilent
11.8.1 Agilent Company Detail
11.8.2 Agilent Business Overview
11.8.3 Agilent Colorectal Cancer Molecular Diagnostics Kit Introduction
11.8.4 Agilent Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2018-2023)
11.8.5 Agilent Recent Development
11.9 Daan Gene
11.9.1 Daan Gene Company Detail
11.9.2 Daan Gene Business Overview
11.9.3 Daan Gene Colorectal Cancer Molecular Diagnostics Kit Introduction
11.9.4 Daan Gene Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2018-2023)
11.9.5 Daan Gene Recent Development
11.10 Ed Bio
11.10.1 Ed Bio Company Detail
11.10.2 Ed Bio Business Overview
11.10.3 Ed Bio Colorectal Cancer Molecular Diagnostics Kit Introduction
11.10.4 Ed Bio Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2018-2023)
11.10.5 Ed Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
